Advisory Board

Jesse L-S Au, Pharm.D., Ph.D.
Distinguished University Professor of Pharmacy, Medicine and Engineering and Davis Chair in Cancer Research at Ohio State University

Webster K. Cavenee, Ph.D.
Director of the Ludwig Institute for Cancer Research and Professor of Medicine at the University of California at San Diego

Roger Cohen, M.D.
Professor of Medicine and Director of Phase I Trials, Fox Chase Cancer Center

Lee Ellis, M.D.
Professor of Surgery and Cancer Biology and the John E. and Dorothy J. Harris Professor in Gastrointestinal Cancer Research, University of Texas M.D. Anderson Cancer Center

Stan Gerson, M.D.
Director, Ireland Cancer Center of University Hospitals of Cleveland and Professor and Director of Case Comprehensive Cancer Center, Case Western Reserve University

Wayne Guida, Ph.D.
Professor, Drug Discovery Program, H. Lee Moffitt Cancer Center & Research Institute and Professor, Departments of Chemistry and Interdisciplinary Oncology, University of South Florida

Robert Kerbel, Ph.D.
Director of Cancer Biology Research at the Sunnybrook and Women's College Health Sciences Centre and Toronto-Sunnybrook Regional Cancer Centre, and the John & Elizabeth Tory Chair of Experimental Oncology at the University of Toronto

Keith McCrae, M.D.
Associate Professor of Medicine in the Hematology-Oncology Division, Case Western Reserve University

K. C. Nicolaou, Ph.D.
Professor of Chemistry , University of California at San Diego, and Chairman of the Department of Chemistry at the Scripps Research Institute

Howard Soule, Ph.D.
Executive Vice  President, Discovery and Translation, Prostate Cancer Foundation

James Taylor, Ph.D.
President of Taylor Associates and a Partner at Merchant-Taylor International, Inc.

Bruce Zetter, Ph.D.
Charles Nowiszewski Professor in the Departments of Cell Biology and Surgery at Harvard Medical School